Results 111 to 120 of about 37,917 (298)

Real-world Data of Antithrombotic Therapy in Neuroendovascular Therapy: Analysis of JR-NET 4

Neurologia Medico-Chirurgica
As the number of neuroendovascular therapies in Japan increases, the current trends in periprocedural antithrombotic therapy must be understood. We retrospectively analyzed data on periprocedural antithrombotic therapy in the Japanese Registry of ...
Nozomi SASAKI, Yukiko ENOMOTO, Hiroshi YAMAGAMI, Koji IIHARA, Akira ISHII, Hirotoshi IMAMURA, Nobuyuki SAKAI, Chiaki SAKAI, Tetsu SATOW, Yuji MATSUMARU, Shinichi YOSHIMURA   +10 more
doaj   +1 more source

Atraumatic Splenic Rupture after Myocardial Infarction

European Journal of Case Reports in Internal Medicine, 2018
Atraumatic splenic rupture is a rare but potentially life-threatening event. It mostly happens when the spleen is already diseased; however, sometimes it can be drug induced in a previously normal spleen.
Muhammad Fahad Arshad, Nasir Javed, Syed Monawer Karim, Ehtasham Ahmad, Noor Ul Ain Abid   +4 more
doaj   +1 more source

The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients

, 2016
Zhong-Guo Fan,1,* Guo-Bin Ding,2,* Xiao-Bo Li,1,3 Xiao-Fei Gao,1,3 Ya-Li Gao,1 Nai-Liang Tian1,3 1Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 2Department of Cardiology, Taixing People’s Hospital, Yangzhou
Li XB, Fan ZG, Gao XF, Tian NL, Ding GB, Gao YL   +5 more
core  

Risk of hemorrhagic stroke in warfarin‐treated patients following heart valve replacement: Findings from the MAGPIE study

Ibrain, EarlyView.
Among 568 mechanical heart valve replacement patients in Bangladesh, hemorrhagic stroke occurred in 4.4% with 52% mortality. Severe pulmonary hypertension increased risk 4.4‐fold, and warfarin therapy ≥104 months nearly doubled the risk, highlighting the need for long‐term risk monitoring in anticoagulated valve patients.
Dipannita Adhikary, Md. Abdullah Yusuf, AM Nayeem Parvez, Sheikh M. B. Faruque, Santo Barman, Adneen Moureen, Luke J. Rogers, Aziz Momin, Venkatachalam Chandrasekaran, Asit B. Adhikary, Redoy Ranjan   +10 more
wiley   +1 more source

Effectiveness of Two-Year Versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis After Drug-Eluting Stent Implantation [PDF]

Journal of Tehran University Heart Center, 2012
Background: Impact of 12 months’ versus 24 months’ use of dual antiplatelet therapy on the prevalence of stent thrombosis in patients undergoing percutaneous coronary intervention (PCI) with the drug-eluting stent (DES) is not clear.
Ali Reza Amirzadegan, Hasan Aghajani, Ali Mohammad Haji Zeinali, Ebrahim Nematipour, Younes Nozari, Mohammad Alidoosti, Seyed Ebrahim Kassaian, Seyed Kianoosh Hosseini, Hamid Reza Poorhosseini, Mojtaba Salarifar, Masoumeh Lotfi Tokaldany, Tahereh Davarpasand   +11 more
doaj   +2 more sources

Triple Therapy or Triple Threat: An Analysis of Triple Antiplatelet Therapy Compared to Dual Antiplatelet Therapy

, 2019
Triple antiplatelet therapy (TAPT, or triple therapy), is an oral medication regimen designed to reduce the risk of major cardiovascular events. It consists of aspirin, clopidogrel or an alternative, and an oral anticoagulant (OAC).
Cwikla, Isabel E., Horvath, Kara C., Hilverding, Austin, Gollmar, Elaina, Petersen, Erin   +4 more
core  

Percutaneous Closure of Patent Foramen Ovale in a Patient With Incomplete Cor Triatriatum Sinister: A Case Report

Journal of Clinical Ultrasound, EarlyView.
We present the case of a 55‐year‐old male who experienced a cryptogenic ischemic stroke, likely due to a patent foramen ovale (PFO) in the setting of an incomplete cor triatriatum sinister (CTS) and a 30 mm GORE Cardioform Septal Occluder was successfully implanted.
Anastasios Apostolos, Maria Drakopoulou, Elias Tolis, Georgios Trantalis, Ioannis Kachrimanidis, Panayotis Vlachakis, Konstantinos Tsioufis, Konstantinos Toutouzas, Konstantina Aggeli   +8 more
wiley   +1 more source

Dual Antiplatelet Therapy for Coronary Artery Disease

Circulation Journal, 2015
Platelets initiate the formation of a thrombus at the site of an arterial injury, and the clotting cascade is activated as the thrombus matures. After coronary stent placement, dual antiplatelet therapy (DAPT) with aspirin and ticlopidine dramatically reduces the risk of stent thrombosis, compared with anticoagulation therapy, and has become the ...
openaire   +3 more sources

Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies

, 2009
Dual antiplatelet therapy is currently recommended for all patients with acute coronary syndromes, independent of whether they receive pharmacological treatment or undergo percutaneous coronary intervention.
Pelc-Nowicka, Agnieszka, Zabojszcz, Michał, Bryniarski, Leszek; 1st Department of Cardiology and Hypertension, Institute of Cardiology, Mirek-Bryniarska, Ewa   +3 more
core  

Evaluating the impact of a newly established hospitalist medicine procedure service on length of stay and procedural outcomes: A retrospective propensity‐matched analysis

Journal of Hospital Medicine, EarlyView.
Abstract Background Reliance on interventional radiology (IR) has been associated with delays in procedure completion and prolonged hospital length of stay (LOS). Hospitalist medicine procedure services (HMPS) have been proposed as a strategy to mitigate these inefficiencies, though outcomes of newly established programs composed of physicians with ...
Jeremy Gentile, Saria Alazmeh, Kriti Soni, Tarek Alsibai, Felicia Wright, Alicia Stowe, Fergus Peacock   +6 more
wiley   +1 more source